McEvoy, John W.
19 papers on CoChatORCID 0000-0001-6530-5479
Most cited papers
- Verified
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal
Health Promotion and Cardiovascular PreventionClinical practice guidelines implementation
Cited by 6,485
- Verified
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation
Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors
Cited by 4,536
- Verified
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal
Blood Pressure and Hypertension StudiesClinical practice guidelines implementation
Cited by 2,298
- Verified · note
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology
Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors
Cited by 1,896
- Verified
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
SCORE2 working group and ESC Cardiovascular risk collaboration, Hageman, S., Pennells, L., Ojeda, F., Kaptoge, S., Kuulasmaa, K., de Vries, T., Xu, Z., Kee, F., Chung, R., et al. (2021) · European Heart Journal
Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors
Cited by 1,810
- Verified
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology
Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors
Cited by 1,193
- Verified
Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)
Blaha, M. J., Cainzos-Achirica, M., Greenland, P., McEvoy, J. W., Blankstein, R., Budoff, M. J., Dardari, Z., Sibley, C. T., Burke, G. L., Kronmal, R. A., et al. (2016) · Circulation
Cardiac Imaging and DiagnosticsCardiovascular Health and Disease Prevention
Cited by 485
- Verified
Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications
Martin, S. S., Blaha, M. J., Elshazly, M. B., Brinton, E. A., Toth, P. P., McEvoy, J. W., Joshi, P. H., Kulkarni, K. R., Mize, P. D., Kwiterovich, P. O., et al. (2013) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 428
- Verified
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe
SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Pennells, L., Kaptoge, S., Østergaard, H. B., Read, S. H., Carinci, F., Franch-Nadal, J., Petitjean, C., Taylor, O., Hageman, S. H. J., et al. (2023) · European Heart Journal
Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention
Cited by 329
- Verified
Obesity and cardiovascular disease: An ESC clinical consensus statement
Koskinas, K. C., Van Craenenbroeck, E. M., Antoniades, C., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Heart Journal
Cardiovascular Function and Risk FactorsObesity, Physical Activity, Diet
Cited by 313
- Verified
The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes
Lee, A. K., Warren, B., Lee, C. J., McEvoy, J. W., Matsushita, K., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2018) · Diabetes Care
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 226
- Verified · note
Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The MESA Study (Multi-Ethnic Study of Atherosclerosis)
Cainzos-Achirica, M., Miedema, M. D., McEvoy, J. W., Al Rifai, M., Greenland, P., Dardari, Z., Budoff, M., Blumenthal, R. S., Yeboah, J., Duprez, D. A., et al. (2020) · Circulation
Antiplatelet Therapy and Cardiovascular DiseasesCardiac Imaging and Diagnostics
Cited by 201
- Verified
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Writing Committee Members, Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., et al. (2026) · Circulation
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 122
- Verified · note
Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults
Elshazly, M. B., Martin, S. S., Blaha, M. J., Joshi, P. H., Toth, P. P., McEvoy, J. W., Al-Hijji, M. A., Kulkarni, K. R., Kwiterovich, P. O., Blumenthal, R. S., et al. (2013) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 68
- Verified
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial
Rahman, F., McEvoy, J. W., Ohkuma, T., Marre, M., Hamet, P., Harrap, S., Mancia, G., Rodgers, A., Selvin, E., Williams, B., et al. (2019) · Hypertension
Blood Pressure and Hypertension StudiesDiabetes Treatment and Management
Cited by 48
- Verified
Glycated albumin and risk of mortality in the US adult population
Rooney, M. R., Daya, N., Tang, O., McEvoy, J. W., Coresh, J., Christenson, R. H., & Selvin, E. (2022) · Clinical Chemistry
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 32
- Verified
Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
Jamal, O., Aneni, E. C., Shaharyar, S., Ali, S. S., Parris, D., McEvoy, J. W., Veledar, E., Blaha, M. J., Blumenthal, R. S., Agatston, A. S., et al. (2014) · Diabetology & Metabolic Syndrome
Adipokines, Inflammation, and Metabolic DiseasesSmoking Behavior and Cessation
Cited by 30
- Verified
Implications of specialist density for diabetes care in the United States.
Patel, R. B., Al Rifai, M., McEvoy, J. W., & Vaduganathan, M. (2019) · JAMA Cardiology
Global Health Workforce IssuesHealthcare Policy and Management
Cited by 28
- Verified
Traditional cardiovascular disease risk factors associated with one-year all-cause mortality among those with coronary artery calcium scores ≥400
Al Rifai, M., McEvoy, J. W., Nasir, K., Rumberger, J., Feldman, D., Budoff, M. J., & Blaha, M. J. (2015) · Atherosclerosis
Cardiac Imaging and DiagnosticsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free